Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Pediatric Nephrology (Berlin, Germany)|June 7, 2013
mTOR inhibitors in pediatric kidney transplantationLars Pape, Thurid AhlenstielPediatric Nephrology (Berlin, Germany)|December 21, 2019
Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantationThurid Ahlenstiel-Grunow, Lars PapePediatric Nephrology (Berlin, Germany)|March 30, 2020
Virus-specific T cells in pediatric renal transplantationThurid Ahlenstiel-Grunow, Lars PapeMolecular and Cellular Pediatrics|July 26, 2021
Novel ways to monitor immunosuppression in pediatric kidney transplant recipients-underlying concepts and emerging dataThurid Ahlenstiel-Grunow, Lars PapePediatric Nephrology (Berlin, Germany)|December 13, 2018
Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantationThurid Ahlenstiel-Grunow, Lars PapeInternational Journal of Nephrology|June 8, 2011
Once-daily tacrolimus extended-release formulation: 1 year after conversion in stable pediatric kidney transplant recipientsLars Pape, Nele Heidotting, Thurid AhlenstielCurrent Opinion in Organ Transplantation|August 15, 2012
Everolimus in pediatric transplantationLars Pape, Rainer Ganschow, Thurid AhlenstielTransplantation|August 2, 2011
Pediatric kidney transplantation followed by de novo therapy with everolimus, low-dose cyclosporine A, and steroid elimination: 3-year dataLars Pape, Frank Lehner, Cornelia Blume, et al.Kidney International|March 13, 2003
Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutionsThurid Ahlenstiel, Gunther Burkhardt, Hans Köhler, et al.Transplantation|January 27, 2006
Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutionsThurid Ahlenstiel, Gunther Burkhardt, Hans Köhler, et al.Pageof 5